Palisade Bio (PALI) Cash & Equivalents (2016 - 2025)
Historic Cash & Equivalents for Palisade Bio (PALI) over the last 16 years, with Q3 2025 value amounting to $5.2 million.
- Palisade Bio's Cash & Equivalents fell 3498.76% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year decrease of 3498.76%. This contributed to the annual value of $9.8 million for FY2024, which is 2100.23% down from last year.
- According to the latest figures from Q3 2025, Palisade Bio's Cash & Equivalents is $5.2 million, which was down 3498.76% from $5.4 million recorded in Q2 2025.
- In the past 5 years, Palisade Bio's Cash & Equivalents registered a high of $16.4 million during Q2 2023, and its lowest value of $615000.0 during Q1 2021.
- For the 5-year period, Palisade Bio's Cash & Equivalents averaged around $10.1 million, with its median value being $11.3 million (2024).
- Over the last 5 years, Palisade Bio's Cash & Equivalents had its largest YoY gain of 177802.93% in 2021, and its largest YoY loss of 9386.84% in 2021.
- Quarter analysis of 5 years shows Palisade Bio's Cash & Equivalents stood at $14.1 million in 2021, then fell by 12.2% to $12.4 million in 2022, then grew by 0.4% to $12.4 million in 2023, then decreased by 21.0% to $9.8 million in 2024, then crashed by 46.78% to $5.2 million in 2025.
- Its Cash & Equivalents was $5.2 million in Q3 2025, compared to $5.4 million in Q2 2025 and $7.2 million in Q1 2025.